Reset filter
Palabras clave
UPALA ×
Mostrar más Palabras clave
Tabla de contenido
  1. 1. Ensayo clínico
  2. 2. Documentación de rutina
  3. 3. Estudio de registro / cohorte
  4. 4. Seguro de calidad
  5. 5. Estándar de datos
  6. 6. Resultado reportado por el paciente
  7. 7. Especialidad médica
Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

19 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Eligibility Inflammation NCT01038674

- 18/4/20 - 1 formulario, 2 itemgroups, 14 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01038674

Eligibility Inflammation NCT00927927

- 18/4/20 - 1 formulario, 2 itemgroups, 12 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00927927

Eligibility Inflammation NCT02097264

- 18/4/19 - 1 formulario, 2 itemgroups, 12 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate; ODM derived from: https://clinicaltrials.gov/show/NCT02097264

Eligibility Inflammation NCT01611688

- 16/1/19 - 1 formulario, 2 itemgroups, 8 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01611688

The Effect of Albiglutide on Cardiac Repolarisation Compared with Placebo 107085 - Liver Biopsy Data: Portal Tract Inflammation

- 20/11/18 - 1 formulario, 3 itemgroups, 17 items, 1 idioma
Itemgroups: Administrative data, Liver Biopsy, G. Portal Tract Inflammation
Study ID: 107085 Clinical Study ID: GLP107085 Study Title: A Randomized, Double-blind, Parallel, Nested Crossover Study to Investigate the Effect of Albiglutide on Cardiac Repolarization (corrected QT Interval) Compared With Placebo in Healthy Male and Female Subjects: A Thorough ECG Study Employing Placebo, Albiglutide, and a Positive Control (Moxifloxacin) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01406262 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Eligibility Inflammation NCT02376738

- 7/5/18 - 1 formulario, 2 itemgroups, 12 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Regional Activation of Leukocytes in Coronary Artery Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02376738

laboratory analysis (resurvey) SHIP-Trend-0 inflammation

- 7/11/17 - 1 formulario, 1 itemgroup, 3 items, 2 idiomas
Itemgroup: inflammation
inflammation form of SHIP Study (Study of Health in Pomerania), conducted by the University of Greifswald. SHIP unique domain name SHIP.SHIPTrend0.LABRE.RE_BLUT.RE_INFL. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html.
 Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial